Literature DB >> 2099535

[Biological profile of tartrate-resistant acid phosphatase as a marker of bone resorption].

H Rico1, M Iritia, I Arribas, M Revilla.   

Abstract

Tartrate-resistant serum acid phosphatase was measured in 123 subjects, 80 of which were normal and the rest pathologic, in order to define the profile and value of this parameter as a biological marker of osteoclastic activity. Normal subjects were divided into age groups based on the period where skeletal growth ends (under 20 years), at the age of menopause in women (50 years, between 20 and 50 years) and those over 50 years. There was an increase in tartrate-resistant serum acid phosphatase coinciding with puberty and no sex differences were observed after the 50 year mark, when women showed higher values than men (p less than 0.001). Such tartrate-resistant serum acid phosphatase increase, is reflected as higher values in the 50 year group than in the 20 to 50 year group (p less than 0.001), the only age limit where a negative significant correlation between tartrate-resistant serum acid phosphatase values and age could be observed (p less than 0.05). Values were higher up to the age of 20 years (p less than 0.001) than in any other older age group. Levels increased significantly (p less than 0.001 for both groups) in post-menopausal osteoporosis (n = 20) and in Paget's disease of bone (n = 15), and decreased significantly (p less than 0.05) in imperfect osteogenesis (n = 8), thus revealing its value as a biological marker of osteoclastic activity.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2099535

Source DB:  PubMed          Journal:  Rev Esp Fisiol        ISSN: 0034-9402


  5 in total

1.  Serum tartrate-resistant acid phosphatase (TRAP) as a biochemical marker of bone remodeling.

Authors:  H Rico; L F Villa
Journal:  Calcif Tissue Int       Date:  1993-02       Impact factor: 4.333

2.  Bone changes in postmenopausal Spanish women.

Authors:  H Rico; E R Hernández; M Revilla; L F Villa; M Alvarez de Buergo; E Cuende
Journal:  Calcif Tissue Int       Date:  1993-02       Impact factor: 4.333

3.  Positive effect of alendronate on bone turnover in ovariectomised rats' osteoporosis: comparison of transdermal lipid-based delivery with conventional oral administration.

Authors:  Mithila Boche; Varsha Pokharkar
Journal:  Drug Deliv Transl Res       Date:  2018-10       Impact factor: 4.617

4.  Total and regional bone mineral content in women treated with GnRH agonists.

Authors:  H Rico; F Arnanz; M Revilla; S Perera; M Iritia; L F Villa; I Arribas
Journal:  Calcif Tissue Int       Date:  1993-05       Impact factor: 4.333

5.  The effect of restriction of dietary calcium on trabecular and cortical bone mineral density in the rats.

Authors:  Changsun Kim; Dongho Park
Journal:  J Exerc Nutrition Biochem       Date:  2013-11-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.